Explore Watchlists Pricing

LIGAND PHARMACEUTICALS INC (LGND) Balance sheet

Market cap

$4.7B

P/E ratio

38.2x

Summary Financials

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	7	12	12	160	97	19	21	120	72	48	20	45	23	72	175
Total cash & short-term investments	7	12	12	160	97	19	21	120	72	48	20	45	23	72	175
Accounts receivable, net	-	-	-	-	-	-	-	-	30	57	85	30	33	38	60
Inventories	1	2	1	0	2	2	4	7	7	26	27	13	24	14	9
Total current assets	32	24	25	185	216	163	237	871	1,124	501	465	264	237	332	832
Property, plant and equipment, net	0	1	1	0	0	2	4	5	7	14	21	12	16	15	-
Total assets	122	104	105	258	534	602	671	1,261	1,495	1,362	1,298	763	787	942	1,561
Accounts payable	11	6	4	8	4	3	2	4	2	4	8	5	2	5	3
Total current liabilities	44	35	29	23	21	227	239	82	17	100	42	99	17	37	37
Total liabilities	105	78	55	234	230	231	252	700	728	653	476	165	86	111	543
Retained earnings	-682	-683	-671	-659	-402	-431	-401	-229	400	392	449	451	503	499	608
Stockholders' equity	-	26	50	26	304	341	400	561	767	710	821	597	701	830	1,017
Working capital	-	-	-	-	-	-	-	-